Disease Du Jour Disease DuJour

In this episode, Erica Secor, DVM, MS, Dipl. ACVS-LA, joined us to discuss her ongoing research on equine osteoarthritis. She talked about her studies on the immune system’s role in osteoarthritis as well as her work towards improving diagnostic capabilities and understanding how arthritis varies among individual horses.
The Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.
Disease Du Jour Podcast Hosts, Guests, and Links Episode 135:
Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Erica Secor, DVM, MS, Dipl. ACVS-LAPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.

In this episode, Alina Vale, DVM, MS, joined us to discuss regulatory veterinary medicine in equine welfare assessments at racetracks and equestrian facilities. She talked about her background working as a regulatory veterinarian for the California Horse Racing Board and explained the procedures that are in place at racetracks to improve safety and welfare for the horses. She also talked about her current work in establishing assessment protocols for other areas of the equine industry.
Disease Du Jour Podcast Hosts, Guests, and Links Episode 134:
Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Alina Vale, DVM, MSPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.
 

In this episode, Nicole Scherrer, DVM, Dipl. ACVO, joined us to talk about equine recurrent uveitis (ERU). She discussed clinical signs, management options, and prognoses, and she provided a brief overview of a potential new treatment option that is currently being researched.
Disease Du Jour Podcast Hosts, Guests, and Links Episode 133:
Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Dr. Nicole Scherrer, DVM, Dipl. ACVOLink: Summary of Dr. Scherrer’s AAEP presentation on novel drug SOCS1-KIRPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.

In this episode, Amelie McAndrews, DVM, DAVDC-Eq, of Garden State Equine Dentistry, joined us to talk about Equine Odontoclastic Tooth Resorption (EOTRH). She discussed the prevalence of the disease and described common clinical signs, management options, and more.
The Disease Du Jour podcast is brought to you by Merck Animal Health.
Disease Du Jour Podcast Hosts, Guests, and Links Episode 132:
Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Amelie McAndrews, DVM, DAVDC-Eq of Garden State Equine DentistryPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.

In this episode, Laura Javsicas, VMD, Dipl. ACVIM, joined us to talk about caring for neonates in the field. During the conversation, she explained her standard newborn foal examination, listed some common conditions she encounters with neonates, and discussed conditions that might require referral to a hospital.
The Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.
Disease Du Jour Podcast Hosts, Guests, and Links Episode 131:
Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Laura Javsicas, VMD, Dipl. ACVIMPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.

In this episode, Jesse Tyma, DVM, Dipl. ACVS, joins us to discuss OCD in horses. She explains some of the risk factors for developing OCD and offers strategies for managing horses with the condition.
Disease Du Jour Podcast Hosts, Guests, and Links Episode 130:
Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Jesse Tyma, DVM, Dipl. ACVSPodcast Website: Disease Du JourThe Disease Du Jour podcast is brought to you in 2024 by Merck Animal Health.